🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Ryan Deschner

Stock Analyst at Raymond James

(4.70)
# 800
Out of 5,162 analysts
77
Total ratings
58.8%
Success rate
28.8%
Average return

Stocks Rated by Ryan Deschner

Alpha Cognition
Nov 12, 2026
Reiterated: Buy
Price Target: $20 → $21
Current: $8.85
Upside: +137.29%
Liquidia
Nov 11, 2026
Reiterated: Buy
Price Target: $53 → $77
Current: $56.63
Upside: +35.97%
Palvella Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $230
Current: $145.77
Upside: +57.78%
ARS Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $17
Current: $3.36
Upside: +405.95%
Vera Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.75
Upside: -
Trevi Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $27 → $40
Current: $13.72
Upside: +191.55%
Tvardi Therapeutics
Jul 8, 2026
Upgraded: Buy
Price Target: $10
Current: $0.9461
Upside: +956.97%
ProQR Therapeutics
Jun 26, 2026
Reiterated: Buy
Price Target: $14 → $10
Current: $1.05
Upside: +852.38%
Achieve Life Sciences
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $5.87
Upside: +240.72%
Viking Therapeutics
Jun 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.84
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $84.83
Upside: -
Initiated Coverage: Buy
Price Target: $21
Current: $13.34
Upside: +57.42%
Reiterated: Buy
Price Target: $9
Current: $1.09
Upside: +725.69%
Reiterated: Buy
Price Target: $110 → $165
Current: $95.51
Upside: +72.76%
Upgraded: Buy
Price Target: $23
Current: $12.19
Upside: +88.68%
Reiterated: Buy
Price Target: $11 → $12
Current: $3.06
Upside: n/a